Cargando…

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations

PURPOSE: Tardive dyskinesia (TD) is a hyperkinetic movement disorder in which patients experience abnormal involuntary movements that can have profound negative impacts on physical, cognitive, and psychosocial functioning. Use of measures to assess the functional impact of TD in routine clinical pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Richard, Brams, Matthew N, Citrome, Leslie, Hoberg, Amber R, Isaacson, Stuart H, Kane, John M, Kumar, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164384/
https://www.ncbi.nlm.nih.gov/pubmed/34079257
http://dx.doi.org/10.2147/NDT.S310605
_version_ 1783701104101425152
author Jackson, Richard
Brams, Matthew N
Citrome, Leslie
Hoberg, Amber R
Isaacson, Stuart H
Kane, John M
Kumar, Rajeev
author_facet Jackson, Richard
Brams, Matthew N
Citrome, Leslie
Hoberg, Amber R
Isaacson, Stuart H
Kane, John M
Kumar, Rajeev
author_sort Jackson, Richard
collection PubMed
description PURPOSE: Tardive dyskinesia (TD) is a hyperkinetic movement disorder in which patients experience abnormal involuntary movements that can have profound negative impacts on physical, cognitive, and psychosocial functioning. Use of measures to assess the functional impact of TD in routine clinical practice is lacking. To address this gap, an advisory panel of experts in psychiatry and movement disorder neurology was convened to develop consensus recommendations on assessment of the impact of TD on patients’ functioning that can be used in clinical practice. METHODS: An advisory panel provided recommendations using an iterative process, beginning with a narrative literature review regarding current practices for assessing the impact of TD in clinical settings. A detailed summary was generated, and the advisory panel provided comments about the content and answered questions about assessing TD impact in clinical practice. The panelists’ responses were discussed during a virtual meeting held on August 28, 2020. A second meeting on September 25, 2020, focused on developing and refining recommendations for assessment of the impact of TD in clinical practice. At the conclusion of the second meeting, general consensus was reached on all recommendation statements. RESULTS: As part of routine clinical practice, it is imperative to assess the impact of TD on the patient’s life to help guide treatment decisions. Key domains for assessing the overall impact of TD include social, physical, vocational, and psychological functioning and the impact of TD on the underlying psychiatric disorder. Assessment of TD impact should be performed at every patient visit. Impact assessments should include consultation with patients, caregivers, and family members. Shared decision-making to initiate TD treatment should consider impact. CONCLUSION: The impact of TD should be assessed routinely, including the key domains of social, physical, vocational, and psychological functioning and the impact of TD on the underlying psychiatric disorder.
format Online
Article
Text
id pubmed-8164384
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81643842021-06-01 Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations Jackson, Richard Brams, Matthew N Citrome, Leslie Hoberg, Amber R Isaacson, Stuart H Kane, John M Kumar, Rajeev Neuropsychiatr Dis Treat Review PURPOSE: Tardive dyskinesia (TD) is a hyperkinetic movement disorder in which patients experience abnormal involuntary movements that can have profound negative impacts on physical, cognitive, and psychosocial functioning. Use of measures to assess the functional impact of TD in routine clinical practice is lacking. To address this gap, an advisory panel of experts in psychiatry and movement disorder neurology was convened to develop consensus recommendations on assessment of the impact of TD on patients’ functioning that can be used in clinical practice. METHODS: An advisory panel provided recommendations using an iterative process, beginning with a narrative literature review regarding current practices for assessing the impact of TD in clinical settings. A detailed summary was generated, and the advisory panel provided comments about the content and answered questions about assessing TD impact in clinical practice. The panelists’ responses were discussed during a virtual meeting held on August 28, 2020. A second meeting on September 25, 2020, focused on developing and refining recommendations for assessment of the impact of TD in clinical practice. At the conclusion of the second meeting, general consensus was reached on all recommendation statements. RESULTS: As part of routine clinical practice, it is imperative to assess the impact of TD on the patient’s life to help guide treatment decisions. Key domains for assessing the overall impact of TD include social, physical, vocational, and psychological functioning and the impact of TD on the underlying psychiatric disorder. Assessment of TD impact should be performed at every patient visit. Impact assessments should include consultation with patients, caregivers, and family members. Shared decision-making to initiate TD treatment should consider impact. CONCLUSION: The impact of TD should be assessed routinely, including the key domains of social, physical, vocational, and psychological functioning and the impact of TD on the underlying psychiatric disorder. Dove 2021-05-24 /pmc/articles/PMC8164384/ /pubmed/34079257 http://dx.doi.org/10.2147/NDT.S310605 Text en © 2021 Jackson et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Jackson, Richard
Brams, Matthew N
Citrome, Leslie
Hoberg, Amber R
Isaacson, Stuart H
Kane, John M
Kumar, Rajeev
Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
title Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
title_full Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
title_fullStr Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
title_full_unstemmed Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
title_short Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
title_sort assessment of the impact of tardive dyskinesia in clinical practice: consensus panel recommendations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164384/
https://www.ncbi.nlm.nih.gov/pubmed/34079257
http://dx.doi.org/10.2147/NDT.S310605
work_keys_str_mv AT jacksonrichard assessmentoftheimpactoftardivedyskinesiainclinicalpracticeconsensuspanelrecommendations
AT bramsmatthewn assessmentoftheimpactoftardivedyskinesiainclinicalpracticeconsensuspanelrecommendations
AT citromeleslie assessmentoftheimpactoftardivedyskinesiainclinicalpracticeconsensuspanelrecommendations
AT hobergamberr assessmentoftheimpactoftardivedyskinesiainclinicalpracticeconsensuspanelrecommendations
AT isaacsonstuarth assessmentoftheimpactoftardivedyskinesiainclinicalpracticeconsensuspanelrecommendations
AT kanejohnm assessmentoftheimpactoftardivedyskinesiainclinicalpracticeconsensuspanelrecommendations
AT kumarrajeev assessmentoftheimpactoftardivedyskinesiainclinicalpracticeconsensuspanelrecommendations